We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$100B
1-Year Est. Return
35.1%
This Fund
S&P 500
This Quarter
Est. Return
+4.99%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+632.23%
AUM
$110B
AUM Growth
+$11.3B
(+11%)
Cap. Flow
+$8.89B
Cap. Flow
% of AUM
8.09%
Top 10 Holdings %
Top 10 Hldgs %
35.27%
Holding
3,643
New
809
Increased
972
Reduced
1,047
Closed
744
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$3.35B |
| 2 |
Vanguard S&P 500 ETF
VOO
|
+$2.85B |
| 3 |
Eli Lilly
LLY
|
+$999M |
| 4 |
Coca-Cola
KO
|
+$685M |
| 5 |
Broadcom
AVGO
|
+$616M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$1.38B |
| 2 |
Apple
AAPL
|
+$1.12B |
| 3 |
Netflix
NFLX
|
+$678M |
| 4 |
Boston Scientific
BSX
|
+$671M |
| 5 |
Cencora
COR
|
+$627M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.19% |
| 2 | Consumer Discretionary | 12.77% |
| 3 | Healthcare | 10.45% |
| 4 | Financials | 7.74% |
| 5 | Communication Services | 5.71% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2651
Acacia Research
ACTG
$465M
| $128K | ﹤0.01% |
34,327
-29,466
| -46% | -$106K |
|
2652
Metagenomi Therapeutics
MGX
$46.3M
| $128K | ﹤0.01% |
79,136
-12,169
| -13% | -$26.3K |
|
2653
Anixa Biosciences
ANIX
$111M
| $127K | ﹤0.01% |
40,558
-22,159
| -35% | -$90.7K |
|
2654
Invesco Mortgage Capital
IVR
$795M
| $126K | ﹤0.01% |
+15,040
| New | +$118K |
|
2655
Fuel Tech
FTEK
$43.1M
| $126K | ﹤0.01% |
+81,011
| New | +$178K |
|
2656
CALL
XP
XP
$8.37B
| $126K | ﹤0.01% |
7,700
-31,100
| -80% | -$548K |
|
2657
MIND Technology
MIND
$45.6M
| $125K | ﹤0.01% |
+14,257
| New | +$143K |
|
2658
Peloton Interactive
PTON
$2.42B
| $124K | ﹤0.01% |
20,100
-434,529
| -96% | -$3.06M |
|
|
LGCY
2659
Legacy Education Inc
LGCY
$142M
| $122K | ﹤0.01% |
11,989
-15,414
| -56% | -$148K |
|
2660
CALL
Southern Company
SO
$105B
| $122K | ﹤0.01% |
1,400
+900
| +180% | +$82.2K |
|
2661
CALL
eBay
EBAY
$47.9B
| $122K | ﹤0.01% |
1,400
| – | – |
|
2662
CALL
Groupon
GRPN
$933M
| $122K | ﹤0.01% |
6,900
-3,800
| -36% | -$71.6K |
|
2663
Coherus Oncology
CHRS
$192M
| $121K | ﹤0.01% |
+85,464
| New | +$125K |
|
2664
Hafnia
HAFN
$3.74B
| $119K | ﹤0.01% |
+22,328
| New | +$133K |
|
2665
Universal Electronics
UEIC
$71.6M
| $119K | ﹤0.01% |
32,840
-3,605
| -10% | -$13.1K |
|
2666
PUT
Autodesk
ADSK
$54.1B
| $118K | ﹤0.01% |
+400
| New | +$121K |
|
|
ORBS
2667
Eightco Holdings
ORBS
$282M
| $118K | ﹤0.01% |
+68,075
| New | +$320K |
|
2668
PUT
Alcoa
AA
$13.6B
| $117K | ﹤0.01% |
2,200
+1,600
| +267% | +$65.5K |
|
|
VWAV
2669
VisionWave Holdings
VWAV
$34.8M
| $117K | ﹤0.01% |
+12,583
| New | +$131K |
|
2670
UNIFI
UFI
$129M
| $116K | ﹤0.01% |
+33,085
| New | +$128K |
|
2671
CALL
FedEx
FDX
$76.9B
| $116K | ﹤0.01% |
400
-700
| -64% | -$184K |
|
2672
PUT
Trip.com Group
TCOM
$29.7B
| $115K | ﹤0.01% |
1,600
-2,400
| -60% | -$172K |
|
2673
CALL
Applied Optoelectronics
AAOI
$11.2B
| $115K | ﹤0.01% |
3,300
+2,100
| +175% | +$62.7K |
|
2674
CALL
Moderna
MRNA
$23.9B
| $115K | ﹤0.01% |
3,900
+3,700
| +1,850% | +$101K |
|
2675
CALL
Natera
NTRA
$45.9B
| $115K | ﹤0.01% |
500
-4,300
| -90% | -$897K |
|
Similar funds
Marshall Wace's Q4 2025 Portfolio in Review
As of Q4 2025, Marshall Wace held 3,643 positions worth $110B, up 11% from $98.6B the previous quarter. Its ten largest holdings account for 35% of the portfolio.
Marshall Wace deployed $8.89B of net new capital in Q4 2025, opening 809 new positions and adding to 972 existing holdings. Its largest new stake was Vanguard S&P 500 ETF: 4,580,704 shares worth $2.87B.
By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 20% a quarter earlier, followed by Consumer Discretionary and Healthcare.
On the sell side, the largest reduction was Microsoft, an estimated $1.38B trimmed.
- Marshall Wace's largest Q4 2025 buy was Vanguard S&P 500 ETF: 4,580,704 shares worth $2.87B.
- Marshall Wace added most to iShares Core S&P 500 ETF in Q4 2025, an estimated $3.35B increase.
- Marshall Wace's biggest Q4 2025 reduction was Microsoft, cutting an estimated $1.38B.
- Marshall Wace fully exited Ares Management in Q4 2025, selling an estimated $146M.
- Marshall Wace's ten largest holdings make up 35% of its $110B portfolio in Q4 2025.
- Marshall Wace opened 809 new positions and closed 744 in Q4 2025.
- Marshall Wace's portfolio value rose 11% quarter-over-quarter to $110B.
Based on Marshall Wace's 13F filing for Q4 2025, filed 13 Feb 2026.